Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga • 10/08/26
Caribou Biosciences (CRBU) Loses 19.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 09/14/26
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/13/26
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 08/13/26
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual ConferenceGlobeNewsWire • 06/29/26
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026GlobeNewsWire • 06/11/26
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual MeetingGlobeNewsWire • 06/11/26
Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/05/26
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/27/26
Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/16/26
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor ConferenceGlobeNewsWire • 05/13/26
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual MeetingGlobeNewsWire • 05/12/26
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/08/26
Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 05/07/26
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care ConferenceGlobeNewsWire • 05/05/26
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell TherapyGlobeNewsWire • 03/31/26
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash ValueSeeking Alpha • 03/17/26
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/05/26
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 03/05/26